NCT04827953
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04827953
Title Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 Before Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer (NUMANTIA)
Acronym NUMANTIA
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nelum Corp
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Clínico Universitario de Santiago Santiago de Compostela A Coruña 15706 Spain Details
Hospital Universitario Virgen De La Victoria Málaga Andalusia 29010 Spain Details
Hospital Universitario Miguel Servet Zaragoza Aragon 50009 Spain Details
Hospital Universitario Donostia Donostia / San Sebastian Basque Country 20014 Spain Details
Hospital Universitari Vall d'Hebron Barcelona Catalonia 08035 Spain Details
Hospital Universitario Marqués del Valdecilla Santander 39008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field